Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan S Jaffe

Showing results (71-80 of 590) with videos related to

Pageof 59
Sort By:
Clinical Chemistry|March 9, 2013
Are biomarkers the answer to the heart failure readmissions problem?Shannon M Dunlay, Allan S Jaffe
Current Opinion in Cardiology|May 9, 2014
Emerging biomarkers for acute heart conditionsVlad C Vasile, Allan S Jaffe
Clinical Chemistry|November 20, 2016
Troponin Autoantibodies: From Assay Interferent to Mediator of CardiotoxicityJason Y Park, Allan S Jaffe
ESC Heart Failure|October 25, 2016
Biomarkers in heart failure: the importance of inconvenient detailsWayne L Miller, Allan S Jaffe
Clinical Chemistry|September 13, 2012
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: user bewareFred S Apple, Allan S Jaffe
JAMA|August 10, 2002
Treatment of depression following acute myocardial infarctionRobert M Carney, Allan S Jaffe
Journal of the American College of Cardiology|December 24, 2016
High-Sensitivity Cardiac Troponin and Primary Prevention: An Important New RoleAllan S Jaffe, R Scott Wright
Clinical Chemistry|May 29, 2024
DPP3 in Cardiogenic ShockAllan S Jaffe, Leslie J Donato
Journal of the American College of Cardiology|May 7, 2013
Reply: To PMID 23395074Fred K Korley, Allan S Jaffe
Journal of the American College of Cardiology|August 4, 2018
1-h High-Sensitivity Troponin Rule-Out and Rule-In Approach: Strengths and Potential WeaknessesJoseph S Alpert, Allan S Jaffe
Pageof 59

Showing results (71-80 of 590) with videos related to

Sort By:
Pageof 59
Clinical Chemistry|March 9, 2013
Are biomarkers the answer to the heart failure readmissions problem?Shannon M Dunlay, Allan S Jaffe
Current Opinion in Cardiology|May 9, 2014
Emerging biomarkers for acute heart conditionsVlad C Vasile, Allan S Jaffe
Clinical Chemistry|November 20, 2016
Troponin Autoantibodies: From Assay Interferent to Mediator of CardiotoxicityJason Y Park, Allan S Jaffe
ESC Heart Failure|October 25, 2016
Biomarkers in heart failure: the importance of inconvenient detailsWayne L Miller, Allan S Jaffe
Clinical Chemistry|September 13, 2012
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: user bewareFred S Apple, Allan S Jaffe
JAMA|August 10, 2002
Treatment of depression following acute myocardial infarctionRobert M Carney, Allan S Jaffe
Journal of the American College of Cardiology|December 24, 2016
High-Sensitivity Cardiac Troponin and Primary Prevention: An Important New RoleAllan S Jaffe, R Scott Wright
Clinical Chemistry|May 29, 2024
DPP3 in Cardiogenic ShockAllan S Jaffe, Leslie J Donato
Journal of the American College of Cardiology|May 7, 2013
Reply: To PMID 23395074Fred K Korley, Allan S Jaffe
Journal of the American College of Cardiology|August 4, 2018
1-h High-Sensitivity Troponin Rule-Out and Rule-In Approach: Strengths and Potential WeaknessesJoseph S Alpert, Allan S Jaffe
Pageof 59